Analyzing Profound Medical (NASDAQ:PROF) & SeaStar Medical (NASDAQ:ICU)

SeaStar Medical (NASDAQ:ICU) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability.

Profitability

This table compares SeaStar Medical and Profound Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-666.82%
Profound Medical	-350.14%	-71.28%	-54.70%

Valuation & Earnings

This table compares SeaStar Medical and Profound Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	N/A	N/A	-$26.23 million	($25.00)	-0.17
Profound Medical	$7.20 million	26.93	-$28.57 million	($1.29)	-6.14

SeaStar Medical has higher earnings, but lower revenue than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 3.0% of SeaStar Medical shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

SeaStar Medical has a beta of -1.13, meaning that its share price is 213% less volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for SeaStar Medical and Profound Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0	0	0	0	N/A
Profound Medical	0	0	3	0	3.00

Profound Medical has a consensus price target of $13.75, suggesting a potential upside of 73.61%. Given Profound Medical’s higher probable upside, analysts plainly believe Profound Medical is more favorable than SeaStar Medical.

Summary

Profound Medical beats SeaStar Medical on 7 of the 12 factors compared between the two stocks.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.